Report Detail

Request for Sample of this report

Other Global IDH1 Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4551324
    • |
  • 22 August, 2023
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global IDH1 Antibody market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global IDH1 Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global IDH1 Antibody market size and forecasts, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (ml), and average selling prices (US$/ml), 2018-2029
Global IDH1 Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (ml), and ASP (US$/ml), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IDH1 Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global IDH1 Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GeneTex, Abcam, BosterBio and Proteintech Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
IDH1 Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal
Polyclonal
Market segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Major players covered
Merck
GeneTex
Abcam
BosterBio
Proteintech Group
Abnova Corporation
Novus Biologicals
NSJ Bioreagents
LifeSpan BioSciences
Abeomics
ProSci
QED Bioscience
Cell Signaling Technology
RayBiotech
EpiGentek
Enzo Life Sciences
OriGene Technologies
Jingjie PTM BioLab
Beijing Solarbio
Biobyt
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IDH1 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IDH1 Antibody, with price, sales, revenue and global market share of IDH1 Antibody from 2018 to 2023.
Chapter 3, the IDH1 Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IDH1 Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and IDH1 Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of IDH1 Antibody.
Chapter 14 and 15, to describe IDH1 Antibody sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of IDH1 Antibody
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global IDH1 Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Monoclonal
    • 1.3.3 Polyclonal
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global IDH1 Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Immunochemistry (IHC)
    • 1.4.3 Immunofluorescence (IF)
    • 1.4.4 Immunoprecipitation (IP)
    • 1.4.5 Western Blot (WB)
    • 1.4.6 ELISA
    • 1.4.7 Others
  • 1.5 Global IDH1 Antibody Market Size & Forecast
    • 1.5.1 Global IDH1 Antibody Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global IDH1 Antibody Sales Quantity (2018-2029)
    • 1.5.3 Global IDH1 Antibody Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck IDH1 Antibody Product and Services
    • 2.1.4 Merck IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 GeneTex
    • 2.2.1 GeneTex Details
    • 2.2.2 GeneTex Major Business
    • 2.2.3 GeneTex IDH1 Antibody Product and Services
    • 2.2.4 GeneTex IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 GeneTex Recent Developments/Updates
  • 2.3 Abcam
    • 2.3.1 Abcam Details
    • 2.3.2 Abcam Major Business
    • 2.3.3 Abcam IDH1 Antibody Product and Services
    • 2.3.4 Abcam IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Abcam Recent Developments/Updates
  • 2.4 BosterBio
    • 2.4.1 BosterBio Details
    • 2.4.2 BosterBio Major Business
    • 2.4.3 BosterBio IDH1 Antibody Product and Services
    • 2.4.4 BosterBio IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 BosterBio Recent Developments/Updates
  • 2.5 Proteintech Group
    • 2.5.1 Proteintech Group Details
    • 2.5.2 Proteintech Group Major Business
    • 2.5.3 Proteintech Group IDH1 Antibody Product and Services
    • 2.5.4 Proteintech Group IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Proteintech Group Recent Developments/Updates
  • 2.6 Abnova Corporation
    • 2.6.1 Abnova Corporation Details
    • 2.6.2 Abnova Corporation Major Business
    • 2.6.3 Abnova Corporation IDH1 Antibody Product and Services
    • 2.6.4 Abnova Corporation IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Abnova Corporation Recent Developments/Updates
  • 2.7 Novus Biologicals
    • 2.7.1 Novus Biologicals Details
    • 2.7.2 Novus Biologicals Major Business
    • 2.7.3 Novus Biologicals IDH1 Antibody Product and Services
    • 2.7.4 Novus Biologicals IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Novus Biologicals Recent Developments/Updates
  • 2.8 NSJ Bioreagents
    • 2.8.1 NSJ Bioreagents Details
    • 2.8.2 NSJ Bioreagents Major Business
    • 2.8.3 NSJ Bioreagents IDH1 Antibody Product and Services
    • 2.8.4 NSJ Bioreagents IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 NSJ Bioreagents Recent Developments/Updates
  • 2.9 LifeSpan BioSciences
    • 2.9.1 LifeSpan BioSciences Details
    • 2.9.2 LifeSpan BioSciences Major Business
    • 2.9.3 LifeSpan BioSciences IDH1 Antibody Product and Services
    • 2.9.4 LifeSpan BioSciences IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 LifeSpan BioSciences Recent Developments/Updates
  • 2.10 Abeomics
    • 2.10.1 Abeomics Details
    • 2.10.2 Abeomics Major Business
    • 2.10.3 Abeomics IDH1 Antibody Product and Services
    • 2.10.4 Abeomics IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Abeomics Recent Developments/Updates
  • 2.11 ProSci
    • 2.11.1 ProSci Details
    • 2.11.2 ProSci Major Business
    • 2.11.3 ProSci IDH1 Antibody Product and Services
    • 2.11.4 ProSci IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 ProSci Recent Developments/Updates
  • 2.12 QED Bioscience
    • 2.12.1 QED Bioscience Details
    • 2.12.2 QED Bioscience Major Business
    • 2.12.3 QED Bioscience IDH1 Antibody Product and Services
    • 2.12.4 QED Bioscience IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 QED Bioscience Recent Developments/Updates
  • 2.13 Cell Signaling Technology
    • 2.13.1 Cell Signaling Technology Details
    • 2.13.2 Cell Signaling Technology Major Business
    • 2.13.3 Cell Signaling Technology IDH1 Antibody Product and Services
    • 2.13.4 Cell Signaling Technology IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Cell Signaling Technology Recent Developments/Updates
  • 2.14 RayBiotech
    • 2.14.1 RayBiotech Details
    • 2.14.2 RayBiotech Major Business
    • 2.14.3 RayBiotech IDH1 Antibody Product and Services
    • 2.14.4 RayBiotech IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 RayBiotech Recent Developments/Updates
  • 2.15 EpiGentek
    • 2.15.1 EpiGentek Details
    • 2.15.2 EpiGentek Major Business
    • 2.15.3 EpiGentek IDH1 Antibody Product and Services
    • 2.15.4 EpiGentek IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 EpiGentek Recent Developments/Updates
  • 2.16 Enzo Life Sciences
    • 2.16.1 Enzo Life Sciences Details
    • 2.16.2 Enzo Life Sciences Major Business
    • 2.16.3 Enzo Life Sciences IDH1 Antibody Product and Services
    • 2.16.4 Enzo Life Sciences IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Enzo Life Sciences Recent Developments/Updates
  • 2.17 OriGene Technologies
    • 2.17.1 OriGene Technologies Details
    • 2.17.2 OriGene Technologies Major Business
    • 2.17.3 OriGene Technologies IDH1 Antibody Product and Services
    • 2.17.4 OriGene Technologies IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 OriGene Technologies Recent Developments/Updates
  • 2.18 Jingjie PTM BioLab
    • 2.18.1 Jingjie PTM BioLab Details
    • 2.18.2 Jingjie PTM BioLab Major Business
    • 2.18.3 Jingjie PTM BioLab IDH1 Antibody Product and Services
    • 2.18.4 Jingjie PTM BioLab IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Jingjie PTM BioLab Recent Developments/Updates
  • 2.19 Beijing Solarbio
    • 2.19.1 Beijing Solarbio Details
    • 2.19.2 Beijing Solarbio Major Business
    • 2.19.3 Beijing Solarbio IDH1 Antibody Product and Services
    • 2.19.4 Beijing Solarbio IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Beijing Solarbio Recent Developments/Updates
  • 2.20 Biobyt
    • 2.20.1 Biobyt Details
    • 2.20.2 Biobyt Major Business
    • 2.20.3 Biobyt IDH1 Antibody Product and Services
    • 2.20.4 Biobyt IDH1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 Biobyt Recent Developments/Updates

3 Competitive Environment: IDH1 Antibody by Manufacturer

  • 3.1 Global IDH1 Antibody Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global IDH1 Antibody Revenue by Manufacturer (2018-2023)
  • 3.3 Global IDH1 Antibody Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of IDH1 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 IDH1 Antibody Manufacturer Market Share in 2022
    • 3.4.2 Top 6 IDH1 Antibody Manufacturer Market Share in 2022
  • 3.5 IDH1 Antibody Market: Overall Company Footprint Analysis
    • 3.5.1 IDH1 Antibody Market: Region Footprint
    • 3.5.2 IDH1 Antibody Market: Company Product Type Footprint
    • 3.5.3 IDH1 Antibody Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global IDH1 Antibody Market Size by Region
    • 4.1.1 Global IDH1 Antibody Sales Quantity by Region (2018-2029)
    • 4.1.2 Global IDH1 Antibody Consumption Value by Region (2018-2029)
    • 4.1.3 Global IDH1 Antibody Average Price by Region (2018-2029)
  • 4.2 North America IDH1 Antibody Consumption Value (2018-2029)
  • 4.3 Europe IDH1 Antibody Consumption Value (2018-2029)
  • 4.4 Asia-Pacific IDH1 Antibody Consumption Value (2018-2029)
  • 4.5 South America IDH1 Antibody Consumption Value (2018-2029)
  • 4.6 Middle East and Africa IDH1 Antibody Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global IDH1 Antibody Sales Quantity by Type (2018-2029)
  • 5.2 Global IDH1 Antibody Consumption Value by Type (2018-2029)
  • 5.3 Global IDH1 Antibody Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global IDH1 Antibody Sales Quantity by Application (2018-2029)
  • 6.2 Global IDH1 Antibody Consumption Value by Application (2018-2029)
  • 6.3 Global IDH1 Antibody Average Price by Application (2018-2029)

7 North America

  • 7.1 North America IDH1 Antibody Sales Quantity by Type (2018-2029)
  • 7.2 North America IDH1 Antibody Sales Quantity by Application (2018-2029)
  • 7.3 North America IDH1 Antibody Market Size by Country
    • 7.3.1 North America IDH1 Antibody Sales Quantity by Country (2018-2029)
    • 7.3.2 North America IDH1 Antibody Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe IDH1 Antibody Sales Quantity by Type (2018-2029)
  • 8.2 Europe IDH1 Antibody Sales Quantity by Application (2018-2029)
  • 8.3 Europe IDH1 Antibody Market Size by Country
    • 8.3.1 Europe IDH1 Antibody Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe IDH1 Antibody Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific IDH1 Antibody Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific IDH1 Antibody Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific IDH1 Antibody Market Size by Region
    • 9.3.1 Asia-Pacific IDH1 Antibody Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific IDH1 Antibody Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America IDH1 Antibody Sales Quantity by Type (2018-2029)
  • 10.2 South America IDH1 Antibody Sales Quantity by Application (2018-2029)
  • 10.3 South America IDH1 Antibody Market Size by Country
    • 10.3.1 South America IDH1 Antibody Sales Quantity by Country (2018-2029)
    • 10.3.2 South America IDH1 Antibody Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa IDH1 Antibody Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa IDH1 Antibody Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa IDH1 Antibody Market Size by Country
    • 11.3.1 Middle East & Africa IDH1 Antibody Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa IDH1 Antibody Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 IDH1 Antibody Market Drivers
  • 12.2 IDH1 Antibody Market Restraints
  • 12.3 IDH1 Antibody Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of IDH1 Antibody and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of IDH1 Antibody
  • 13.3 IDH1 Antibody Production Process
  • 13.4 IDH1 Antibody Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 IDH1 Antibody Typical Distributors
  • 14.3 IDH1 Antibody Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on IDH1 Antibody. Industry analysis & Market Report on IDH1 Antibody is a syndicated market report, published as Global IDH1 Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of IDH1 Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,745.72
    		4,118.58
    		5,491.44
    		3,250.32
    		4,875.48
    		6,500.64
    		548,030.40
    		822,045.60
    		1,096,060.80
    		290,858.40
    		436,287.60
    		581,716.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo